/term/e10/XKRX:004310 Hyundai Pharmaceutical Co (XKRX:004310) E10
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » E10

Hyundai Pharmaceutical Co (XKRX:004310) E10 : ₩26.37 (As of Feb. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Hyundai Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hyundai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Feb. 2024 was ₩12.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩26.37 for the trailing ten years ended in Feb. 2024.

During the past 12 months, Hyundai Pharmaceutical Co's average E10 Growth Rate was 70.80% per year. During the past 3 years, the average E10 Growth Rate was 70.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hyundai Pharmaceutical Co was 70.50% per year. The lowest was -49.20% per year. And the median was -23.80% per year.

As of today (2024-06-20), Hyundai Pharmaceutical Co's current stock price is ₩3585.00. Hyundai Pharmaceutical Co's E10 for the quarter that ended in Feb. 2024 was ₩26.37. Hyundai Pharmaceutical Co's Shiller PE Ratio of today is 135.95.

During the past 13 years, the highest Shiller PE Ratio of Hyundai Pharmaceutical Co was 17583.33. The lowest was 49.22. And the median was 229.33.


Hyundai Pharmaceutical Co E10 Historical Data

The historical data trend for Hyundai Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Pharmaceutical Co E10 Chart

Hyundai Pharmaceutical Co Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.54 5.60 -11.24 11.63 27.74

Hyundai Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.44 24.01 28.07 27.74 26.37

Competitive Comparison of Hyundai Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Hyundai Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyundai Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hyundai Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hyundai Pharmaceutical Co's Shiller PE Ratio falls into.



Hyundai Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hyundai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=12/118.8477*118.8477
=12.000

Current CPI (Feb. 2024) = 118.8477.

Hyundai Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201405 16.560 99.481 19.784
201408 14.612 99.672 17.423
201411 19.482 99.108 23.362
201502 10.715 99.710 12.772
201505 22.405 100.030 26.620
201508 9.741 100.370 11.534
201511 25.327 99.920 30.125
201602 13.638 100.820 16.077
201605 18.508 100.810 21.820
201608 9.741 100.860 11.478
201611 12.664 101.450 14.836
201702 14.612 102.920 16.873
201705 25.327 102.830 29.272
201708 11.689 103.370 13.439
201711 -115.758 102.620 -134.063
201802 15.000 104.210 17.107
201805 17.000 104.340 19.364
201808 11.000 104.850 12.469
201811 -120.000 104.710 -136.202
201902 16.000 104.690 18.164
201905 22.000 105.050 24.890
201908 -27.000 104.810 -30.616
201911 4.000 104.870 4.533
202002 5.000 105.800 5.617
202005 106.000 104.710 120.312
202008 -34.000 105.500 -38.302
202011 1.000 105.500 1.127
202102 -35.000 107.083 -38.845
202105 16.000 107.579 17.676
202108 -8.000 108.317 -8.778
202111 -87.000 109.497 -94.429
202202 42.000 111.005 44.968
202205 86.000 113.387 90.142
202208 87.000 114.505 90.300
202211 -221.000 115.011 -228.373
202302 61.000 116.360 62.304
202305 115.000 117.151 116.666
202308 65.000 118.416 65.237
202311 -15.000 118.848 -15.000
202402 12.000 118.848 12.000

Add all the adjusted EPS together and divide 10 will get our e10.


Hyundai Pharmaceutical Co  (XKRX:004310) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hyundai Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3585.00/26.37
=135.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Hyundai Pharmaceutical Co was 17583.33. The lowest was 49.22. And the median was 229.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hyundai Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Pharmaceutical Co (XKRX:004310) Business Description

Traded in Other Exchanges
N/A
Address
Bonegeunsa Street 135, Hyundai Pharm Building, Gangnam-gu, Seoul, KOR, 135-545
Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.

Hyundai Pharmaceutical Co (XKRX:004310) Headlines

No Headlines